Bipolar Disorder

Bipolar disorder study shows lack of treatment, frequent mistreatment

Published in Biotech Law Weekly, July 2nd, 2004

New data presented at the National Institute of Mental Health's 44th Annual New Clinical Drug Evaluation Unit (NCDEU) meeting revealed that as many as 45% of bipolar patients received no specific drug treatment for bipolar disorder in the first 2 months following a bipolar diagnosis.

In addition, 62% of this "no-treatment" group received antidepressants, which are contraindicated with bipolar disorder treatment guidelines.

Further analysis presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 9th annual meeting in Arlington, Virginia, showed that, compared with use of mood stabilizer monotherapy, use of newer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2004-07-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database